MS is an inflammatory demyelinating condition. This means it is caused by damage to myelin – a fatty material that insulates nerves, acting much like the covering of an electric wire. Myelin allows a nerve to transmit its impulses rapidly. It is the speed and efficiency with which these impulses are conducted that permits smooth, rapid and co-ordinated movements to be performed with little conscious effort.
Source: MS international federation
MS is a progressive disease of the central nervous system, for which there is no cure at present.
MS is the most common disease of the central nervous system in young adults.
MS is not directly hereditary, although genetic susceptibility plays a part in its development.
Diagnosis of MS is generally between 20 and 40 years of age, although onset may be earlier.
Source: MS international federation
Innovative research and development is important for multiple sclerosis (MS) because it is the key to finding new and better treatments for this chronic and often debilitating disease. MS is a complex disorder, and there is still much that we don’t understand about its causes and how it progresses. By conducting research, scientists and medical professionals can gain a deeper understanding of MS and identify new targets for treatment.
In addition, innovative research and development led to the development of therapies that can help to slow the progression of the disease and reduce the severity of symptoms.
Overall, innovative research and development is essential for advancing the field of MS and improving the lives of individuals affected by the disease. Without it, we would not have the treatments and therapies that are currently available to patients.
Our mission is to create access to high-quality generic medicines for all patients. We believe in our trusted partnerships to achieve our goals. If you would like to discuss partnering opportunities, get in touch.
